HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kamran Ghaedi Selected Research

actinomycin D1

1/2021Integrated pan-cancer of AURKA expression and drug sensitivity analysis reveals increased expression of AURKA is responsible for drug resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kamran Ghaedi Research Topics

Disease

25Neoplasms (Cancer)
06/2022 - 05/2016
18Breast Neoplasms (Breast Cancer)
05/2022 - 05/2016
8Multiple Sclerosis
08/2022 - 01/2014
8Autoimmune Diseases (Autoimmune Disease)
08/2022 - 01/2013
8Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 03/2014
6Stomach Neoplasms (Stomach Cancer)
05/2022 - 12/2016
6Inflammation (Inflammations)
08/2021 - 04/2015
5Obesity
09/2022 - 11/2018
4Insulin Resistance
09/2022 - 07/2021
4Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 01/2020
4Rhizomelic Chondrodysplasia Punctata
07/2014 - 03/2002
3Neoplasm Metastasis (Metastasis)
02/2022 - 01/2020
3Demyelinating Diseases (Demyelinating Disease)
08/2021 - 10/2017
3Nervous System Diseases (Neurological Disorders)
05/2021 - 03/2014
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021 - 01/2014
3Spinal Cord Injuries (Spinal Cord Injury)
04/2018 - 01/2013
2Cardiotoxicity
06/2022 - 01/2018
2Parkinson Disease (Parkinson's Disease)
01/2022 - 01/2019
2Prediabetic State (Prediabetes)
01/2022 - 07/2021
2Weight Gain
01/2022 - 01/2021
2Diabetes Complications
03/2021 - 01/2021
2Glioma (Gliomas)
01/2021 - 07/2018
2Carcinogenesis
10/2019 - 01/2019
1Colonic Neoplasms (Colon Cancer)
09/2022
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
08/2022
1Psoriasis (Pustulosis Palmaris et Plantaris)
08/2022
1Rheumatoid Arthritis
08/2022
1Endometriosis
04/2022
1Triple Negative Breast Neoplasms
01/2022
1Dyslexia (Alexia)
10/2021
1Type 2 Diabetes Mellitus (MODY)
10/2021
1Chromosomal Instability (Chromosome Stability)
09/2021
1COVID-19
09/2021
1Colitis
08/2021
1Body Weight (Weight, Body)
07/2021
1Glucose Intolerance
07/2021
1Hypoxia (Hypoxemia)
06/2021
1Mitochondrial Diseases (Mitochondrial Disease)
05/2021
1Hyperglycemia
01/2021
1Uterine Neoplasms (Uterine Cancer)
01/2021
1Leukemia
01/2021

Drug/Important Bio-Agent (IBA)

24MicroRNAs (MicroRNA)IBA
05/2022 - 07/2014
13Biomarkers (Surrogate Marker)IBA
08/2022 - 07/2014
8Messenger RNA (mRNA)IBA
08/2021 - 02/2010
7Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2010
6Pharmaceutical PreparationsIBA
01/2022 - 01/2017
4Long Noncoding RNAIBA
05/2022 - 07/2021
4RNA (Ribonucleic Acid)IBA
05/2022 - 11/2020
4Insulin (Novolin)FDA Link
01/2022 - 07/2018
43' Untranslated Regions (3' UTR)IBA
01/2021 - 08/2016
3Pioglitazone (Actos)FDA Link
06/2022 - 03/2014
3Doxorubicin (Adriamycin)FDA LinkGeneric
06/2022 - 01/2018
3Blood Glucose (Blood Sugar)IBA
01/2022 - 01/2021
3IronIBA
01/2017 - 03/2015
3Peroxisomal Targeting Signal 2 ReceptorIBA
04/2013 - 03/2002
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
09/2022 - 04/2015
22-chloro-5-nitrobenzanilideIBA
06/2022 - 04/2018
2Estrogens (Estrogen)FDA Link
04/2022 - 10/2019
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2022 - 07/2018
2Biological ProductsIBA
10/2021 - 01/2021
2Estrogen ReceptorsIBA
09/2021 - 05/2020
2Brain-Derived Neurotrophic Factor (BDNF)IBA
05/2021 - 03/2016
2Metformin (Glucophage)FDA LinkGeneric
03/2021 - 01/2021
2Progesterone Receptors (Progesterone Receptor)IBA
05/2020 - 10/2019
2CytokinesIBA
01/2020 - 12/2019
2MyokinesIBA
01/2020 - 11/2014
2Hormones (Hormone)IBA
10/2019 - 04/2018
2DNA (Deoxyribonucleic Acid)IBA
10/2019 - 01/2013
2LipidsIBA
11/2018 - 07/2014
2LigandsIBA
04/2018 - 03/2014
1Nonesterified Fatty Acids (NEFA)IBA
09/2022
1Antineoplastic Agents (Antineoplastics)IBA
06/2022
1human MIRN612 microRNAIBA
05/2022
1Sirolimus (Rapamycin)FDA Link
01/2022
1Chlorogenic AcidIBA
01/2022
1CoffeeFDA Link
01/2022
1steroid receptor RNA activatorIBA
11/2021
1Glucose (Dextrose)FDA LinkGeneric
11/2021
1Small Interfering RNA (siRNA)IBA
09/2021
1Interleukin-6 (Interleukin 6)IBA
08/2021
1Peroxidase (Myeloperoxidase)IBA
08/2021
1Sirtuin 1IBA
08/2021
1Bee Venoms (Bee Venom)IBA
08/2021
1Peptides (Polypeptides)IBA
08/2021
1Therapeutic UsesIBA
08/2021
1ApaminIBA
08/2021
1CuprizoneIBA
08/2021
1Protamines (Protamine Sulfate)FDA Link
07/2021
1diacetyldichlorofluoresceinIBA
07/2021
14,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA
07/2021
1Advanced Glycation End ProductsIBA
07/2021
1activin AIBA
06/2021
1LuciferasesIBA
02/2021
1Protein Kinases (Protein Kinase)IBA
01/2021
1Vincristine (Oncovin)FDA LinkGeneric
01/2021
1Cytarabine (Cytosar-U)FDA LinkGeneric
01/2021
1actinomycin D1IBA
01/2021
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2021

Therapy/Procedure

10Therapeutics
06/2022 - 01/2014
5Drug Therapy (Chemotherapy)
02/2022 - 01/2018